OCT Variability Prevents Their Use as Robust Biomarkers in Multiple Sclerosis

References

• Jones-Odeh E, Hammond CJ. How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis? Eye (Lond). 2015;29(10):1270–1284. doi:10.1038/eye.2015.158
   Web of Science ®Google Scholar
• Petzold A, Balcer LJ, Calabresi PA, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16(10):797–812. doi:10.1016/S1474-4422(17)30278-8
   PubMed Web of Science ®Google Scholar
• Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40(11):2520–2527.
   PubMed Web of Science ®Google Scholar
• Oberwahrenbrock T, Schippling S, Ringelstein M, et al. Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int. 2012;2012:530305. doi:10.1155/2012/530305
   PubMedGoogle Scholar
• Saidha S, Sotirchos ES, Oh J, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol. 2013;70(1):34–43. doi:10.1001/jamaneurol.2013.573
   PubMed Web of Science ®Google Scholar
• Saidha S, Al-Louzi O, Ratchford JN, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol. 2015;78(5):801–813. doi:10.1002/ana.24487
   PubMed Web of Science ®Google Scholar
• Balk LJ, Tewarie P, Killestein J, et al. Disease course heterogeneity and OCT in multiple sclerosis. Mult Scler J. 2014;20(9):1198–1206. doi:10.1177/1352458513518626
   Web of Science ®Google Scholar
• Brandt AU, Martinez-Lapiscina EH, Nolan R, Saidha S. Monitoring the course of MS with optical coherence tomography. Curr Treat Options Neurol. 2017;19(4):15. doi:10.1007/s11940-017-0452-7
   Web of Science ®Google Scholar
• Lambe J, Murphy OC, Saidha S. Can optical coherence tomography be used to guide treatment decisions in adult or pediatric multiple sclerosis? Curr Treat Options Neurol. 2018;20(4):9. doi:10.1007/s11940-018-0493-6
   PubMed Web of Science ®Google Scholar
• Behbehani R, Adnan H, Al-Hassan AA, Al-Salahat A, Alroughani R. Predictors of retinal atrophy in multiple sclerosis: a longitudinal study using spectral domain optical coherence tomography with segmentation analysis. Mult Scler Relat Disord. 2018;21(2):56–62. doi:10.1016/j.msard.2018.02.010
   Web of Science ®Google Scholar
• Carcelén‐Gadea M, Quintanilla‐Bordás C, Gracia‐García A, et al. Functional and structural changes in the visual pathway in multiple sclerosis. Brain Behav. 2019;9(12):e01467. doi:10.1002/brb3.1467
   Web of Science ®Google Scholar
• Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M. Optical coherence tomography in Alzheimer’s disease and other neurodegenerative diseases. Front Neurol. 2017;8:701. doi:10.3389/fneur.2017.00701
   PubMed Web of Science ®Google Scholar
• van Velthoven ME, Faber DJ, Verbraak FD, van Leeuwen TG, de Smet MD. Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res. 2007;26(1):57–77. doi:10.1016/j.preteyeres.2006.10.002
   PubMed Web of Science ®Google Scholar
• Miller AR, Roisman L, Zhang Q, et al. Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2017;58(3):1499–1505. doi:10.1167/iovs.16-20969
   PubMed Web of Science ®Google Scholar
• Davila JR, Mruthyunjaya P. Updates in imaging in ocular oncology. F1000Research. 2019;8:1706. doi:10.12688/f1000research.19979.1
   Google Scholar
• Watson GM, Keltner JL, Chin EK, et al. Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis. J Neuroophthalmol. 2011;31(2):110–116. doi:10.1097/WNO.0b013e3181facbbd
   Web of Science ®Google Scholar
• Matlach J, Wagner M, Malzahn U, Göbel W. Repeatability of peripapillary retinal nerve fiber layer and inner retinal thickness among two spectral domain optical coherence tomography devices. Invest Ophthalmol Vis Sci. 2014;55(10):6536–6546. doi:10.1167/iovs.14-15072
   PubMed Web of Science ®Google Scholar
• Leite MT, Rao HL, Weinreb RN, et al. Agreement among spectral-domain optical coherence tomography instruments for assessing retinal nerve fiber layer thickness. Am J Ophthalmol. 2011;151(1):85–92.e1. doi:10.1016/j.ajo.2010.06.041
   Web of Science ®Google Scholar
• Oertel FC, Zimmermann HG, Brandt AU, Paul F. Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis. Expert Rev Neurother. 2018;27:1–13.
   Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. doi:10.1016/S1474-4422(17)30470-2
   PubMed Web of Science ®Google Scholar
• Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2016;86(24):2303–2309. doi:10.1212/WNL.0000000000002774
   PubMed Web of Science ®Google Scholar
• Schippling S, Balk LJ, Costello F, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler J. 2015;21(2):163–170. doi:10.1177/1352458514538110
   PubMed Web of Science ®Google Scholar
• Jindahra P, Hedges TR, Mendoza-Santiesteban CE, Plant GT. Optical coherence tomography of the retina: applications in neurology. Curr Opin Neurol. 2010;23(1):16–23. doi:10.1097/WCO.0b013e328334e99b
   PubMed Web of Science ®Google Scholar
• Costello F, Burton JM. Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis? Eye Brain. 2018;10:47–63. doi:10.2147/EB.S139417
   Web of Science ®Google Scholar
• Satue M, Obis J, Rodrigo MJ, et al. Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases. J Ophthalmol. 2016;2016:8503859. doi:10.1155/2016/8503859
   PubMed Web of Science ®Google Scholar
• Wong BM, Cheng RW, Mandelcorn ED, et al. Validation of optical coherence tomography retinal segmentation in neurodegenerative disease. Transl Vis Sci Technol. 2019;8(5):6. doi:10.1167/tvst.8.5.6
   Web of Science ®Google Scholar
• Garcia-Martin E, Satue M, Fuertes I, et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson’s disease. Ophthalmology. 2012;119(10):2161–2167. doi:10.1016/j.ophtha.2012.05.003
   PubMed Web of Science ®Google Scholar
• Chan VTT, Sun Z, Tang S, et al. Spectral-domain OCT measurements in Alzheimer’s disease: a systematic review and meta-analysis. Ophthalmology. 2019;126(4):497–510. doi:10.1016/j.ophtha.2018.08.009
   PubMed Web of Science ®Google Scholar
• Sánchez D, Castilla-Marti M, Rodríguez-Gómez O, et al. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease. Sci Rep. 2018;8(1):16345. doi:10.1038/s41598-018-34577-3
   Web of Science ®Google Scholar
• Sánchez D, Castilla-Marti M, Marquié M, et al. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic. Sci Rep. 2020;10(1):1580. doi:10.1038/s41598-020-58399-4
   Web of Science ®Google Scholar
• Rebolleda G, Diez-Alvarez L, Casado A, et al. OCT: new perspectives in neuro-ophthalmology. Saudi J Ophthalmol. 2015;29(1):9–25. doi:10.1016/j.sjopt.2014.09.016
   PubMed Web of Science ®Google Scholar
• Lanzillo R, Cennamo G, Criscuolo C, et al. Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Mult Scler J. 2018;24(13):1706–1714. doi:10.1177/1352458517729463
   PubMed Web of Science ®Google Scholar
• Cennamo G, Carotenuto A, Montorio D, et al. Peripapillary vessel density as early biomarker in multiple sclerosis. Front Neurol. 2020;11:542. doi:10.3389/fneur.2020.00542
   PubMed Web of Science ®Google Scholar
• Huo YJ, Guo Y, Li L, et al. Age-related changes in and determinants of macular ganglion cell-inner plexiform layer thickness in normal Chinese adults. Clin Experiment Ophthalmol. 2018;46(4):400–406. doi:10.1111/ceo.13067
   Web of Science ®Google Scholar
• Mauschitz MM, Bonnemaijer PWM, Diers K, et al. Systemic and ocular determinants of peripapillary retinal nerve fiber layer thickness measurements in the European Eye Epidemiology (E3) population. Ophthalmology. 2018;125(10):1526–1536. doi:10.1016/j.ophtha.2018.03.026
   Web of Science ®Google Scholar
• Costello F, Hodge W, Pan YI, Eggenberger E, Freedman MS. Using retinal architecture to help characterize multiple sclerosis patients. Can J Ophthalmol. 2010;45(5):520–526. doi:10.3129/i10-063
   Web of Science ®Google Scholar
• Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59(6):963–969. doi:10.1002/ana.20851
   PubMed Web of Science ®Google Scholar
• Coric D, Balk LJ, Verrijp M, et al. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Mult Scler J. 2018;24(2):158–166. doi:10.1177/1352458517694090
   PubMed Web of Science ®Google Scholar
• Coric D, Balk LJ, Uitdehaag BMJ, Petzold A. Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis. Eur J Neurol. 2017;24(12):1479–1484. doi:10.1111/ene.13443
   PubMed Web of Science ®Google Scholar
• González-López JJ, Rebolleda G, Leal M, et al. Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int. 2014;2014:128517. doi:10.1155/2014/128517
   Web of Science ®Google Scholar
• Albrecht P, Ringelstein M, Müller AK, et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler J. 2012;18(10):1422–1429. doi:10.1177/1352458512439237
   Web of Science ®Google Scholar
• Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135(Pt 2):521–533. doi:10.1093/brain/awr264
   Web of Science ®Google Scholar
• Domínguez-Vicent A, Brautaset R, Venkataraman AP. Repeatability of quantitative measurements of retinal layers with SD-OCT and agreement between vertical and horizontal scan protocols in healthy eyes. PLoS One. 2019;14(8):e0221466. doi:10.1371/journal.pone.0221466
   Web of Science ®Google Scholar
• Töteberg-Harms M, Sturm V, Knecht PB, Funk J, Menke MN. Repeatability of nerve fiber layer thickness measurements in patients with glaucoma and without glaucoma using spectral-domain and time-domain OCT. Graefes Arch Clin Exp Ophthalmol. 2012;250(2):279–287. doi:10.1007/s00417-011-1811-9
   Web of Science ®Google Scholar
• Gundogan FC, Demirkaya S, Sobaci G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?–A structural and functional evaluation. Invest Ophthalmol Vis Sci. 2007;48(12):5773–5781. doi:10.1167/iovs.07-0834
   Web of Science ®Google Scholar
• Ziccardi L, Barbano L, Boffa L, et al. Functional assessment of outer and middle macular layers in multiple sclerosis. J Clin Med. 2020;9(11):3766. doi:10.3390/jcm9113766
   Web of Science ®Google Scholar